Erratum: Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: A systematic review (Human Psychopharmacology (2007) vol. 22 (121-128) 10.1002/hup.836);Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: A systematic review

Human Psychopharmacology

Volumn 22, Issue 3, 2007, Pages 121-128

  Bellantuono, Cesario ^a   Migliarese, Giovanni ^a   Gentile, Salvatore ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b ASL Salerno 1   (Italy)

Author keywords

Antidepressants; Major malformations; Pregnancy; Selective serotonin inhibitors (SRIs)

Indexed keywords

CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

CASE CONTROL STUDY; CLINICAL TRIAL; COCHRANE LIBRARY; COHORT ANALYSIS; CONGENITAL MALFORMATION; DEPRESSION; DRUG EXPOSURE; FIRST TRIMESTER PREGNANCY; HUMAN; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SAMPLE SIZE; SYSTEMATIC REVIEW; TERATOGENICITY;

EID: 34248327959     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.867     Document Type: Erratum

References (60)

1. Addis A, Koren G. 2000. Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies. Psychol Med 30: 89-94.
2. Alwan S, Reefhuis J, Rasmussen S, Olney R, Friedman JM. 2005. Maternal use of selective serotonin re-uptake inhibitors and risk for birth defects [abstract]. Terat Soc Abst 291.
3. Andersson L, Sundstrom-Poromaa I, Bixo M, et al. 2003. Point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study. Am J Obstet Gynecol 189: 148-154.
4. American Psychiatric Association (APA). 2000. Practice guideline for the treatment of patients with major depressive disorders. Am J Psychiatry 157: 1-45.
5. Austin MP 2006. To treat or not to treat: maternal depression, SSRI use in pregnancy and adverse neonatal effects. Psychol Med 36: 1663-1670.
6. Baghai TC, Volz HP, Moller HJ. 2006. Drug treatment of depression in the 2000s: an overview of achievement in the last 10 years and future possibilities. World J Biol Psychiatry 7: 198-222.
7. Bellantuono C, Mazzi M, Rizzo R, Tansella M, Goldberg D. 2002. The identification of depression and the coverage of antidepressant drug prescriptions in Italian general practice. J Affect Disord 72: 53-59.
8. Bonari L, Bennett H, Einarson A, Koren G. 2004. Risks of untreated depression during pregnancy. Can Fam Physician 50: 37-39.
9. Bonari L, Koren G, Einarson TR, Jasper JD, Taddio A, Einarson A. 2005. Use of antidepressant by pregnant women. Evaluation of perception of risk, efficacy of evidence based counselling and determinants of decision making. Arch Womens Ment Health 8: 214-220.
10. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. 1996. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335: 1010-1015.
11. Cohen L, Nonacs R. (eds). Mood and Anxiety Disorders during Pregnancy and Post-partum. American Psychiatric Publishing, Inc.: Washington; 2005.
12. Cohen LS, Altshuler LL, Harlow BL, et al. 2006. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295: 499-507.
13. De Las Cuevas C, Sanz EJ. 2006. Safety of selective serotonin reuptake inhibitors in pregnancy. Curr Drug Saf 1: 17-24.
14. Diav-Citrin O, Shechtman S, Weinbaum D, et al. 2005. Paroxetine and fluoxetine in pregnancy: a multicenter, prospective, controlled study [Abstract]. Reprod Toxicol 20: 459.
15. Einarson TR, Einarson A. 2005. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 14: 823-827.
16. Einarson A, Fatoye B, Sarkar M, et al. 2001. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry 158: 1728-1730.
17. Ericson A, Kallen B, Wiholm B. 1999. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol 55: 503-508.
18. Evans J, Heron J, Francomb H, Oke S, Golding J. 2001. Cohort study of depressed mood during pregnancy and after childbirth. BMJ 323: 257-260.
19. Gentile S. 2005a. The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf 28: 137-152.
20. Gentile S. 2005b. SSRIs in pregnancy and lactation. Emphasis on neurodevelopmental outcome. CNS Drugs 19: 1-8.
21. Gentile S. 2005c. More than half of women with a history of psychosis have a psychiatric episode in the first year after childbirth [Invited commentary]. Evid Based Ment Health 8: 33.
22. Gentile S. 2007. SRI-induced perinatal complications. Paediatr Drugs (in press).
23. GSK. On line database, retrieved at http://ctr.gsk.co.uk/summary/ paroxetine/studylist.asp (last accessed on October 29, 2006).
24. Hampton T. 2006. Antidepressants and pregnancy: weighing risk and benefits no easy task. JAMA 295: 1631-1632.
25. Headley J, Northstone K, Simmons H, Golding J. 2004. ALSPAC study team. Medication use during pregnancy: data from the AVON study of parents and children. Eur J Clin Pharmacol 60: 335-361.
26. Heikkinen T, Ekblad U, Kero P, Ekblad S, Laine K. 2002. Citalopram in pregnancy and lactation. Clin Pharmacol Ther 72: 184-191.
27. Hemels MEH, Einarson A, Koren G, Lanctôt KL, Einarson TR. 2005. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother 39: 803-809. 10.1345/aph.1E547.
28. Heron J, O'Connor TG, Evans J, Golding J, Glover V. 2004. The course of anxiety and depression through pregnancy and the postpartum in a community sample. J Affect Disord 80: 65-73.
29. Hirshefeld RMA. 2001. The comorbidity of major depression and anxiety disorders: recognition and management in primary care. Prim Care Companion J Clin Psychiatry 3: 244-254.
30. Holmes LB, Harvey EA, Coull BA, et al. 2001. The teratogenicity of anticonvulsant drugs. New Engl J Med 334: 1132-1138.
31. Kallen BA, Otterblad Olausson P. 2003. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 17: 255-261.
32. Kallen B, Otterblad Olausson P. 2006. Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 21: 221-222.
33. Kulin NA, Pastuszak A, Sage SR, et al. 1998. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 279: 609-610.
34. Lewinson PM, Olino TM, Klein DN. 2005. Psychosocial impairment in offspring of depressed parents. Psychol Med 35: 1-11.
35. Malm H, Klaukka T, Neuvonen PJ. 2005. Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 106: 1289-1296.
36. Misri S, Oberlander TF, Fairbrother N, et al. 2004. Relation between prenatal maternal mood and anxiety and neonatal health. Can J Psychiatry 49: 684-689.
37. Mitchell AA. 2003. Systematic identification of drugs that cause birth defects: a new opportunity. N Engl J Med 349: 2556-2559.
38. Montgomery S, de Boer J. (ed.). SSRIs in Depression and Anxiety (2nd edition). Wiley & Sons: Chicester, UK; 2001.
39. Moses-Kolko EL, Brogen D, Perel A, Uhl K, Levin B, Wisner KL. 2005. Neonatal signs after late in utero exposure to SRIs: a literature review and implication for clinical implications. JAMA 293: 2372-2383.
40. Nemeroff CB, Owens MJ. 2004. Pharmacological differences among SSRIs: focus on monoamine transporters and HPA axis. CNS Spectrum 6: 23-31.
41. Nordeng H, Spigest O. 2005. Treatment with SSRIs in the third trimester of pregnancy. Drug Saf 28: 565-581.
42. Nulman I, Rovet J, Stewart DE, Shuhaiber S, Koren G. 2002. Child development following exposure to tricyclic antidepressants or fluoxetine trough fetal life: a prospective, controlled study. Am J Psychiatry 159: 1889-1895.
43. Oates M. 2003. Suicide: the leading cause of maternal death. Brit J Psychiatry 183: 279-281.
44. Oberlander TF, Warburton W, Misri S, Agajanian J, Hertzman C. 2006. Neonatal outcomes after prenatal exposure to SSRIs anti-depressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 63: 898-906.
45. Pastuszak A, Schick-Boschetto B, Zuber C, et al. 1993. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 269: 2246-2248.
46. Rahimi R, Nifkar S, Abdollahi M. 2006. Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials. Reprod Toxicol 2: 571-575.
47. Rubinow D. 2006. Antidepressant treatment during pregnancy: between Scylla and Caribdi. Am J Psychiatry 163: 954-955.
48. Sanz EJ, De las Cuevas C, Kiuru A, Bate A, Edwards R. 2005. SSRIs in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 365: 482-487.
49. Shadigian E, Bauer S. 2005. Pregnancy-associated death: a qualitative systematic review of homicide and suicide. Obstet Gynecol Survey 60: 183-190.
50. Shirm E, Meijer WM, Tobi H, de Jong-van der Berg LT. 2004. Drug use by pregnant women and comparable non-pregnant women in the Netherlands with reference to Australian classification system. Eur J Obstet Gynecol Reprod Biol 114: 182-188.
51. Simon GE, Cunningham ML, Davis RL. 2002. Outcomes of prenatal antidepressant exposure. Am J Psychiatry 159: 2055-2061.
52. Sivojelezova A, Shuhaiber S, Sarkissian L, Einarson A, Koren G. 2005. Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. Am J Obstet Gynecol 193: 2004-2009.
53. Spinelli MG, Endicott J. 2003. Controlled clinical trial of interpersonal psychotherapy versus parenting education program for depressed pregnant women. Am J Psychiatry 160: 555-562.
54. Stahl S. (ed.). Essential Psychopharmacology (2nd edition). Cambridge University Press: Cambridge, UK; 2000.
55. Ververs T, Kaasenbrood H, Visser G, Schobben F, de Jong-van den Berg L, Egberts T. 2006. Prevalence and patterns of antidepressant drug use during pregnancy. Eur J Clin Pharmacol 62: 863-870.
56. Weissman MM, Wickramaratne P, Nomura Y, Warner V, Pilovsky D, Verdeli H. 2006. Offspring of depressed parents: 20 years later. Am J Psychiatry 163: 1001-1008.
57. Wen SW, Yang Q, Garner P, et al. 2006. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 194: 961-966.
58. Wisner KL, Gelenberg AJ, Leonard H, Zarin D, Frank E. 1999. Pharmacologic treatment of depression during pregnancy. JAMA 282: 1264-1269.
59. Wogelius P, Norgaard M, Gislum M, et al. 2006. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology 17: 701-704.
60. Zuckerman B, Amaro H, Bauchner H, Cabral H. 1989. Depressive symptoms during pregnancy: relationship to poor health behaviors. Am J Obstet Gynecol 160: 1107-1111.